Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0K4XQ
|
||||
Former ID |
DNC007472
|
||||
Drug Name |
MCL-431
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [528655] | ||
Structure |
Download2D MOL |
||||
Formula |
C20H28N2O2
|
||||
Canonical SMILES |
CCNC(=O)OC1=CC2=C(CC3C4C2(CCCC4)CCN3C)C=C1
|
||||
InChI |
1S/C20H28N2O2/c1-3-21-19(23)24-15-8-7-14-12-18-16-6-4-5-9-20(16,17(14)13-15)10-11-22(18)2/h7-8,13,16,18H,3-6,9-12H2,1-2H3,(H,21,23)
|
||||
InChIKey |
ZNJDUQHDGFWNKK-UHFFFAOYSA-N
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Kappa-type opioid receptor | Target Info | Inhibitor | [528655] | |
Delta-type opioid receptor | Target Info | Inhibitor | [528655] | ||
Mu-type opioid receptor | Target Info | Inhibitor | [528655] | ||
NetPath Pathway | TCR Signaling Pathway | ||||
PANTHER Pathway | Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathway | ||||
Heterotrimeric G-protein signaling pathway-Gq alpha and Go alpha mediated pathway | |||||
Opioid prodynorphin pathwayP00026:Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathway | |||||
Enkephalin release | |||||
Opioid proenkephalin pathway | |||||
Opioid proopiomelanocortin pathwayP00026:Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathway | |||||
Pathway Interaction Database | IL4-mediated signaling events | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.